Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CIAO2A pseudogene 2 (CIAO2AP2) is a human pseudogene annotated in genome databases and sometimes referenced as FAM96AP2. Unlike its protein-coding paralog CIAO2A, which is involved in cytosolic iron-sulfur cluster assembly and protein maturation, CIAO2AP2 does not encode a functional protein and currently has no documented biological activity, disease associations, or relevance as a drug target. It is not considered a receptor, enzyme, transporter, or therapeutic target by prevailing molecular classification systems. In summary, CIAO2A pseudogene 2 (CIAO2AP2) is a pseudogene, does not function as a molecular target, and should not be classified among conventional therapeutic targets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CIAO2A pseudogene 2 (CIAO2AP2).